Topical delivery of PD‐1 inhibitors with laser‐assisted passive diffusion and active intradermal injection: Investigation of cutaneous pharmacokinetics and biodistribution patterns-Reference-Cited by-同舟云学术

Topical delivery of PD‐1 inhibitors with laser‐assisted passive diffusion and active intradermal injection: Investigation of cutaneous pharmacokinetics and biodistribution patterns

Published:2021-12-02 Issue:1 Volume:54 Page:170-181
ISSN:0196-8092
Container-title:Lasers in Surgery and Medicine
language:en
Short-container-title:Lasers Surg Med

Author:

Christensen Rikke L.¹^ORCID,Hendel Kristoffer K.¹^ORCID,Persson Daniel P.²^ORCID,Husted Søren²^ORCID,Olesen Uffe H.¹^ORCID,Haedersdal Merete¹^ORCID

Affiliation:

1. Department of Dermatology and Wound Healing Centre Copenhagen University Hospital ‐ Bispebjerg and Frederiksberg Copenhagen Denmark

2. Department of Plant and Environmental Sciences, Faculty of Science University of Copenhagen Frederiksberg Denmark

Publisher

Wiley

Subject

Dermatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lsm.23504

Reference32 articles.

1. Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

2. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

3. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012

4. FDA. Research C for DE and. FDA approves cemiplimab‐rwlc for locally advanced and metastatic basal cell carcinoma. Accessed July 13 2021.https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-cemiplimab-rwlc-locally-advanced-and-metastatic-basal-cell-carcinoma

5. Association Between Programmed Death Ligand 1 Expression in Patients With Basal Cell Carcinomas and the Number of Treatment Modalities

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laser‐assisted topical delivery of vismodegib reduces hedgehog gene expression in human basal cell carcinomas in vivo;Lasers in Surgery and Medicine;2024-02-04

2. Laser microporation facilitates topical drug delivery: a comprehensive review about preclinical development and clinical application;Expert Opinion on Drug Delivery;2022-12-15

3. Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser;Cancers;2022-11-25

4. Optical Imaging Visualizes a Homogeneous and Horizontal Band-Like Biodistribution of Large- and Small-Size Hydrophilic Compounds Delivered by Ablative Fractional Laser;Pharmaceutics;2022-07-23

5. Introduction to 2022 special dermatology/plastic surgery issue;Lasers in Surgery and Medicine;2022-01